Bsenexus Terminal Open in Bsenexus App →
CONFERENCE_CALL BSE: 532296

Glenmark Pharmaceuticals Ltd

Glenmark Pharmaceuticals Ltd - 532296 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Schedule of Analyst/ Institutional Investor Meetings